Skip to content

Artificial Intelligence, and E-Health Literacy in Fibromyalgia

An Investigation on Artificial Intelligence Literacy and E-Health Literacy of Patients With Fibromyalgia Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07020845
Enrollment
212
Registered
2025-06-13
Start date
2024-12-16
Completion date
2025-05-30
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia Syndrome, Healthy Controls Group - Age and Sex-matched

Keywords

Fibromyalgia Syndrome, Artificial Intelligence Literacy, Electronic Health Literacy, Revised Fibromyalgia Impact Questionnaire, Beck Depression Inventory, Beck Anxiety Inventory

Brief summary

This cross-sectional observational study aimed to assess electronic health literacy and artificial intelligence literacy among individuals diagnosed with fibromyalgia syndrome, with particular focus on artificial intelligence literacy. Although general health literacy has been investigated in this patient population, digital and artificial intelligence-related competencies have not been sufficiently studied. The research included 106 individuals diagnosed with fibromyalgia syndrome and 106 age- and sex-matched healthy volunteers, recruited between December 2024 and May 2025. All participants completed a series of standardized questionnaires, including the Revised Fibromyalgia Impact Questionnaire, the Beck Depression Inventory, the Beck Anxiety Inventory, the Electronic Health Literacy Scale, and the Artificial Intelligence Literacy Scale. The study explored demographic, clinical, and psychological factors associated with digital and artificial intelligence literacy levels among both patient and control groups.

Interventions

OTHERObservation only

This is an observational study with no intervention applied to participants. Data were collected through questionnaires and clinical assessments only

Sponsors

Gulseren Demir Karakilic
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Age between 18 and 50 years Diagnosis of Fibromyalgia Syndrome according to 2016 American College of Rheumatology criteria (for patient group) Adequate cognitive function Literacy Willingness to participate and provide informed consent For control group: Healthy individuals matched by age and sex, with no reported health issues

Exclusion criteria

Cognitive impairment preventing questionnaire completion Illiteracy Presence of severe comorbidities or neurological/psychiatric disorders that may affect participation Refusal or inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
E-Health LiteracyAt baselineAn 8-item, 5-point Likert-type scale developed by Norman and Skinner , validated in Turkish by Tamer Gencer. Higher scores indicate higher e- Health Literacy
Artificial Intelligence LiteracyAt baselineA 12-item, 7-point Likert-type scale developed by Wang et al . and adapted into Turkish by Çelebi et al . Higher scores indicate greater Artificial Intelligence literacy

Secondary

MeasureTime frameDescription
the Revised Fibromyalgia Impact QuestionnaireAt baselineaims to measure patients with fibromyalgia syndrome status, progress and outcomes through 21 questions that inquire about physical functions, work-related situations, depression, anxiety, waking up tired, pain, stiffness, and fatigue The Turkish adaptation of the Revised Fibromyalgia Impact Questionnairewas psychometrically evaluated for validity and reliability by Sarmer et al .
the Beck Depression InventoryAt baselineis developed by Beck and colleagues in 1961, is intended to evaluate the typical signs and symptoms associated with depression. This instrument is a self-administered questionnaire comprising 21 items and usually requires around 10 minutes to complete. The Turkish version of the inventory was adapted and validated by Hisli and colleagues
Beck Anxiety InventoryAt baselineis developed by Aaron T. Beck, is an internationally validated tool for assessing anxiety levels. It consists of 21 items. The Turkish adaptation and validation of the inventory were performed by Ulusoy and colleagues

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026